Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 104 Fallopian Tube Neoplasms 47 Carcinoma, Ovarian Epithelial 27 Neoplasms 12 Breast Neoplasms 7 Neoplasm Metastasis 5 Recurrence 4 Endometrial Neoplasms 4 Uterine Cervical Neoplasms 3 Triple Negative Breast Neoplasms 3 Peritoneal Neoplasms 3 Ovarian Cancer Recurrent 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma 3 Multiple Myeloma 2 Lung Neoplasms 2 Disease Progression 2 Colorectal Neoplasms 2 Breast Neoplasms, Male 2 Waldenstrom Macroglobulinemia 1 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Vaccinia 1 Urinary Bladder Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Sezary Syndrome 1 Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma 1

Interventions

Saline Solution 3 Carboplatin 2 Bevacizumab 2 talazoparib 1 stenoparib 1 senaparib 1 sargramostim 1 olaparib 1 niraparib 1 liposomal doxorubicin 1 Tranexamic Acid 1 Ropivacaine 1 Paclitaxel 1 Observation 1 Neoadjuvant Therapy 1 Hyperthermic Intraperitoneal Chemotherapy 1 Antineoplastic Agents 1 1-dodecylpyridoxal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Ovarian Cancer × liposomal doxorubicin × Gynecologic × Clear all

NCT03161132 2023-01-27

ROLANDO

Grupo Español de Investigación en Cáncer de Ovario

Phase 2 Completed

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡